Skip to main content
. 2021 Mar 15;12:608625. doi: 10.3389/fimmu.2021.608625

Figure 5.

Figure 5

Inhibition of PI3K∂ by idelalisib alters neither monocyte nor neutrophil function. (A) Compiled data showing the phagocytic capacity of monocytes after 4 h in the presence of different concentrations of idelalisib or DMSO as vehicle control; n = 12 HDs. (B) Representative kinetic trace of the oxygen consumption rate (OCR) and compiled bar chart depicting the oxidative burst of neutrophils as areas under the curve (AUC) in a Seahorse XF neutrophil activation assay; n = 8 HDs.